Both biotechs are a bit risky, but could benefit from clinical progress this year -- and the upside would be huge. CRISPR has ...
The Chosun Ilbo on MSN
Obesity treatments surpass Keytruda in global sales
Last year, sales of obesity treatments surpassed Keytruda, the immune anticancer drug that had long held the top sales ...
Abstract: This work presents a comparative analysis of total ionizing dose (TID) effects in modern commercial 4H-SiC MOSFETs, including both planar and trench-gate architectures from five ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback